NYSE$AMN
AMN Healthcare Services Inc. · Q2 2022 earnings
Q2 2022 earnings · · Investor relations
Briefing
AMN Healthcare's Q2 2022 revenue and earnings surpassed expectations due to robust demand and strong market performance.
AMN Healthcare announced strong second quarter 2022 results with revenue of $1.427 billion, a 66% increase over the prior year. GAAP EPS was $2.77, and adjusted EPS was $3.31. The company's performance was driven by robust demand and strong market conditions.
- Consolidated revenue for the quarter was $1.427 billion, a 66% increase over prior year.
- Net income was $124 million, or $2.77 per diluted share, compared to $67 million, or $1.39 per diluted share, in Q2 2021.
- Adjusted diluted EPS in the second quarter was $3.31 compared with $1.64 in the same quarter of the prior year.
- The company acquired Connetics USA in mid-May, contributing $2 million to the revenue.
Headline financials
Revenue & EPS history
AMN Healthcare · Revenue · Quarterly
$1.43B
Revenue by segment
AMN Healthcare · $1.43B total across 3 segments · Q2 2022
- Nurse & Allied Solutions$1.1B+76.3%77.2%
- Physician & Leadership$176M+26.5%12.3%
- Technology & Workforce$149M+58.8%10.4%
Forward guidance
Revenue in the third quarter of 2022 is expected to be 23-26% higher than prior year and 22-24% lower sequentially.
Tailwinds
- Nurse and Allied Solutions segment revenue is expected to grow 24-28% year over year, which includes $7 million from labor disruption activities.
- For the Physician and Leadership Solutions segment, revenue is expected to be approximately 15% higher than prior year.
- Technology and Workforce Solutions segment revenue is expected to grow by approximately 30% year over year.
Headwinds
- The quarter-over-quarter decline is due primarily to the anticipated travel nurse and VMS bill rate reductions, which have come down slightly less than our prior expectations.
Historical earnings impact
How earnings announcements have historically affected this stock's price.
Avg. return before/after earnings
Based on 20 quarterly earnings reports · overlaid with Q2 2022
-0.0%
Avg return
Earnings day
-1.9%
Avg return
5 days after
-0.6%
Avg return
30 days after
52%
34 / 66 earnings
Positive
+29.2%
Q1 2026
Best reaction
-29.5%
Q3 2024
Worst reaction
| Quarter | Report date | Reaction (Day 0) | +5 days | +30 days |
|---|---|---|---|---|
| Q1 2026 | +29.2% | +38.5% | +41.5% | |
| Q4 2025 | +11.4% | +15.8% | +4.2% | |
| Q3 2025 | -3.4% | -10.0% | -11.8% | |
| Q2 2025 | +2.3% | +10.2% | +23.2% | |
| Q1 2025 | +8.2% | +7.1% | +3.8% | |
| Q4 2024 | +6.7% | +0.5% | -6.8% | |
| Q3 2024 | -29.5% | -36.7% | -36.2% | |
| Q2 2024 | -3.1% | -11.9% | -24.0% | |
| Q1 2024 | -9.3% | +3.4% | -10.1% | |
| Q4 2023 | -20.9% | -25.5% | -24.7% | |
| Q3 2023 | -12.2% | -17.7% | -9.5% | |
| Q2 2023 | -16.4% | -16.6% | -18.6% | |
| Q1 2023 | +7.7% | +10.3% | +18.0% | |
| Q4 2022 | -4.0% | -2.3% | -13.4% | |
| Q3 2022 | -7.5% | -0.4% | +1.7% | |
| Q2 2022 | +1.8% | -1.7% | -12.7% | |
| Q1 2022 | -8.2% | -10.6% | -1.3% | |
| Q4 2021 | +8.8% | +5.3% | +10.4% | |
| Q3 2021 | -8.2% | -1.4% | +3.7% | |
| Q2 2021 | +5.4% | +3.8% | +15.4% | |
| Q1 2021 | +7.6% | +10.3% | +11.0% | |
| Q4 2020 | +4.1% | -0.7% | +1.4% | |
| Q3 2020 | -5.8% | -7.0% | -1.9% | |
| Q2 2020 | +4.8% | -4.5% | -1.7% | |
| Q1 2020 | -9.3% | -12.1% | +13.0% | |
| Q4 2019 | +9.6% | +5.6% | +4.0% | |
| Q3 2019 | -0.5% | +2.1% | +0.8% | |
| Q2 2019 | +7.7% | +11.4% | +15.5% | |
| Q1 2019 | +1.9% | -0.4% | -6.0% | |
| Q4 2018 | -12.5% | -14.7% | -26.7% | |
| Q3 2018 | +13.3% | +11.6% | +23.9% | |
| Q2 2018 | -15.2% | -10.4% | -5.4% | |
| Q1 2018 | -21.9% | -21.6% | -14.6% | |
| Q4 2017 | +4.8% | +4.8% | +10.9% | |
| Q3 2017 | -3.6% | -1.6% | +16.3% | |
| Q2 2017 | +1.1% | +6.9% | +4.4% | |
| Q1 2017 | -6.8% | -6.2% | -9.0% | |
| Q4 2016 | +4.0% | +7.9% | +10.3% | |
| Q3 2016 | -1.6% | -2.7% | -7.8% | |
| Q2 2016 | -11.9% | -13.8% | -13.5% | |
| Q1 2016 | +1.0% | — | — | |
| Q4 2015 | +1.8% | — | — | |
| Q3 2015 | +5.9% | — | — | |
| Q2 2015 | +0.1% | — | — | |
| Q1 2015 | -1.4% | — | — | |
| Q4 2014 | +2.0% | — | — | |
| Q3 2014 | -1.7% | — | — | |
| Q2 2014 | +5.7% | — | — | |
| Q1 2014 | +3.8% | — | — | |
| Q4 2013 | +1.4% | — | — | |
| Q4 2012 | +13.4% | — | — | |
| Q3 2013 | +13.4% | — | — | |
| Q2 2013 | +6.1% | — | — | |
| Q1 2013 | -1.3% | — | — | |
| Q3 2012 | +4.0% | — | — | |
| Q2 2012 | +5.5% | — | — | |
| Q1 2011 | +19.4% | — | — | |
| Q1 2012 | +6.1% | — | — | |
| Q4 2011 | -2.0% | — | — | |
| Q4 2009 | -2.0% | — | — | |
| Q3 2011 | -3.7% | — | — | |
| Q3 2010 | -3.7% | — | — | |
| Q4 2010 | -1.4% | — | — | |
| Q2 2010 | -1.4% | — | — | |
| Q2 2011 | -1.4% | — | — | |
| Q1 2010 | -0.1% | — | — |
Discussion
Share your read of this quarter. Sign-in carries your eToro identity.
Join the conversation
Sign in with eToro to post your read of this quarter and vote on others'.
Sign in with eToro